Gurugram-based startup Genes2Me has recently launched its brand new product RT- Direct Multiplex RT-PCR kit for COVID-19.

The kit is based on the gold standard RT-PCR method with coverage of three target genes specific to SARS-COV-2 along with IC, which is much advanced than all others having 1 or 2 target genes.

This greatly increases the sensitivity of the RTPCR test to detect samples with different mutations/variants as this kit targets three different Sars-cov-2 target regions.

Validated at the Indian Council of Medical Research (ICMR) approved Centre with 100 per cent sensitivity and specificity, the newly launched kit can deliver results in just 40 minutes.

RT-Direct test protocol does not require any manual extraction step or automated instrument, making it faster and easier to deliver results. It will also increase the throughput of any testing lab by threefold compared to the normal RT-PCR test protocol time of 120-150 minutes. The company has also received DCGI approval for this kit.

The kit is now easily available in India from the second week of November 2021 and for the international market, it will be available after a global launch at Medica, event on November 15 at Messe Dusseldorf, Germany.